Cantel Medical Corp. (CMD) Analysts See $0.60 EPS

November 11, 2018 - By Mona Holcomb

Analysts expect Cantel Medical Corp. (NYSE:CMD) to report $0.60 EPS on December, 6.They anticipate $0.03 EPS change or 5.26 % from last quarter’s $0.57 EPS. CMD’s profit would be $25.02M giving it 35.12 P/E if the $0.60 EPS is correct. After having $0.62 EPS previously, Cantel Medical Corp.’s analysts see -3.23 % EPS growth. The stock increased 1.19% or $0.99 during the last trading session, reaching $84.28. About 180,301 shares traded. Cantel Medical Corp. (NYSE:CMD) has risen 15.63% since November 11, 2017 and is uptrending. It has outperformed by 0.01% the S&P500.

Cantel Medical Corp. provides infection prevention services and products for the healthcare market worldwide. The company has market cap of $3.52 billion. The firm operates through four divisions: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis. It has a 38.66 P/E ratio. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services.

Another recent and important Cantel Medical Corp. (NYSE:CMD) news was published by Prnewswire.com which published an article titled: “Cantel Appoints Bill Haydon to Senior Vice President and General Manager of Medical Division” on November 01, 2018.

Cantel Medical Corp. (NYSE:CMD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: